RTP biotechnology firm begins human trials for potential COVID-19 treatment
Research Triangle Park-based BioCryst will conduct trials to see if its experimental yellow fever drug is effective against COVID-19.
Powered by WPeMatico
- RTP biotechnology firm begins human trials for potential COVID-19 treatment
- No New Emoji in 2021 as Pandemic Is Also Delaying the Release of Emoji 14.0